Women's Health managers
Dedicated investment managers focused on conditions affecting women uniquely, differently or disproportionately.
Calabar Capital is building an allocator-led investment platform designed to provide diversified access to specialist investment managers across Women's Health and Healthcare AI.
Women's Health identifies where substantial unmet need remains. Healthcare AI expands what may now be possible.
Women's Health represents one of healthcare's largest areas of unmet need. Across many conditions, scientific understanding, clinical pathways and investment remain behind the scale of the patient population and economic burden.
At the same time, Healthcare AI is changing how diseases are detected, understood and treated—from diagnostics and drug discovery to clinical decision-making and care delivery.
Together, these forces are creating new possibilities across healthcare.
Women's Health identifies where change is needed. Healthcare AI expands what is possible.

Women's Health and Healthcare AI span biotechnology, pharmaceuticals, diagnostics, medical devices, digital health and care delivery. They also extend across different stages, business models and geographies.
Specialist managers bring distinct knowledge, networks and access to different parts of this opportunity. Calabar Capital partners with complementary managers and brings their expertise together within a diversified institutional portfolio.
In a fragmented market, manager selection and portfolio construction become sources of investment value.
Calabar Capital is developing a multi-manager investment platform designed to bring together complementary sources of specialist healthcare expertise within one portfolio. The investment universe may include:
Dedicated investment managers focused on conditions affecting women uniquely, differently or disproportionately.
Specialist managers investing in the technologies transforming healthcare research, diagnostics, clinical decision-making and care delivery.
Healthcare and life-sciences managers with meaningful exposure to relevant conditions, technologies or business models.
Selected opportunities where Women's Health and Healthcare AI converge.
This approach is intended to provide diversification across managers, healthcare domains, company stages and geographies—while preserving access to specialist knowledge.

Access to managers with dedicated knowledge, networks and sourcing capabilities.
A disciplined assessment of investment strategy, team quality, portfolio construction, differentiation and execution capability.
Exposure across multiple managers, healthcare domains, company stages and geographies.
A deliberate approach to position sizing, risk concentration, capital pacing and the interaction between underlying strategies.
Ongoing manager monitoring, portfolio-level analysis and consolidated reporting.
The potential to participate in selected opportunities arising from underlying manager relationships, where appropriate.
Calabar's platform and any future investment activities remain under development and subject to the completion of all applicable legal, regulatory and operational arrangements.
Calabar Capital is being built by professionals whose experience spans institutional investing, private wealth, investment governance and financial-services regulation. Our starting point is not a single technology, company or venture strategy. It is the portfolio-level question:
How can long-term investors access these opportunities with appropriate specialist expertise, diversification and institutional discipline?
Our approach is grounded in evaluating investment managers, structures and portfolios through evidence, incentives and decision-making under uncertainty.
We look beyond compelling narratives and headline track records to examine where an investment advantage originates and whether it may be repeatable.
We consider each manager not only individually, but in relation to the role it could perform, its overlap with other exposures and the risks it could introduce.
Our thinking is informed by sustained engagement with healthcare innovation, specialist investors and the structural blind spots that have left important biological differences insufficiently understood.

Calabar Capital's investment approach is informed by research into how institutional capital can evaluate and access emerging healthcare opportunities. Maryann publishes her public analysis through The Billion Dollar Blindspot, an independent knowledge and publishing platform covering Women's Health investing, Healthcare AI and capital allocation.
An institutional framework for the principal routes available to investors—and the different risks, capabilities and portfolio implications of each.
An assessment of the opportunity through the lens of demand, capital flows, portfolio construction and private-wealth allocation.
Why the intersection of unmet healthcare need and enabling technology may create a distinctive investment opportunity.

Founder and Chief Investment Officer
Maryann Selfe is an institutional investor with more than twenty years of experience across private banking, wealth and asset management, portfolio construction, manager selection, investment risk and capital allocation.
Before founding Calabar Capital, she advised family offices and institutional investors and held senior investment responsibility across more than CHF 5 billion in mandates. She is the author of The Billion Dollar Blindspot and Founder and President of FemmeHealth Alliance.

Co-Founder and Managing Partner
Jillian MacNab is a Swiss financial-services lawyer with experience across investment structures, financial regulation, governance and institutional platform development.
As Co-Founder and Managing Partner of Calabar Capital, Jillian helps shape the firm's governance, organisational development and operating structure. She works alongside Maryann to translate the investment strategy into a credible, institutionally robust platform designed to meet the expectations of investors, regulators and strategic partners.
Calabar Capital forms part of a wider body of work focused on strengthening the Women's Health investment ecosystem.
The institutional investment platform.
The public research, publishing and intellectual platform.
An independent non-profit organisation focused on ecosystem development, education, collaboration and convening.
Each organisation has a distinct role. Together, they contribute to the knowledge, relationships and investment infrastructure needed for capital to participate more confidently in Women's Health.
This form is provided by Typeform. To load it, please allow functional and embedded-content cookies.